Steven Cohen's TRAX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 408,330 shares of First Tracks Biotherapeutics, Inc. (TRAX) worth $8.22 M, representing 0.01% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in TRAX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's First Tracks Biotherapeutics (TRAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly First Tracks Biotherapeutics (TRAX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +408,330 | New Buy | 408,330 | $20.12 |
Steven Cohen's First Tracks Biotherapeutics Investment FAQs
Steven Cohen first purchased First Tracks Biotherapeutics, Inc. (TRAX) in Q2 2026, acquiring 408,330 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held First Tracks Biotherapeutics, Inc. (TRAX) for 1 quarters since Q2 2026.
Steven Cohen's largest addition to First Tracks Biotherapeutics, Inc. (TRAX) was in Q2 2026, adding 408,330 shares worth $8.22 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 408,330 shares of First Tracks Biotherapeutics, Inc. (TRAX), valued at approximately $8.22 M.
As of the Q2 2026 filing, First Tracks Biotherapeutics, Inc. (TRAX) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in First Tracks Biotherapeutics, Inc. (TRAX) was 408,330 shares, as reported at the end of Q2 2026.